Psyence Biomedical Ltd.

NASDAQ: PBM · Real-Time Price · USD
3.22
-0.13 (-3.88%)
At close: Aug 15, 2025, 3:59 PM
3.28
1.63%
After-hours: Aug 15, 2025, 07:36 PM EDT

Psyence Biomedical Cash Flow Statement

Financials in USD. Fiscal year is undefined.
Fiscal Year FY 2023 FY 2022 FY 2021
Period Ending Mar 31, 2024 Mar 31, 2023 Mar 31, 2022
Net Income
-51.16M 8.01M 8.23M
Depreciation & Amortization
240.00 n/a n/a
Stock-Based Compensation
317.88K 221.29K 332.07K
Other Working Capital
-1.28M -54.44K -504.88K
Other Non-Cash Items
49.07M -8.48M -8.56M
Deferred Income Tax
n/a n/a n/a
Change in Working Capital
-1.17M -54.44K -504.88K
Operating Cash Flow
-2.95M -519.6K -839.17K
Capital Expenditures
-5.73K n/a n/a
Cash Acquisitions
n/a n/a n/a
Purchase of Investments
n/a n/a -255M
Sales Maturities Of Investments
n/a n/a n/a
Other Investing Acitivies
n/a n/a -32.04K
Investing Cash Flow
-5.73K n/a -255M
Debt Repayment
2.35M n/a n/a
Common Stock Repurchased
n/a n/a n/a
Dividend Paid
n/a n/a n/a
Other Financial Acitivies
n/a 1.17M -1.63M
Financial Cash Flow
2.35M 1.17M 256.49M
Net Cash Flow
-601.09K -519.61K -4.16M
Free Cash Flow
-2.95M -519.6K -839.17K